Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence
High-performance saliva-based diagnosis High-performance saliva-based diagnosis The Ziwig Endotest® was evaluated through the analysis of 109 salivary microRNAs, combining next-generation sequencing (NGS) with artificial intelligence. Diagnostic interpretations were performed blindly, without prior knowledge of the patients' clinical status, ensuring full methodological independence and robustness. The NEJM Evidence publication highlights exceptional diagnostic performance: These...
PR Newswire
02/12/2025
Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing…
Together, these results and the investment from the EIB, position Xeltis to advance confidently toward commercialization, bringing aXess – a revolutionary, first of its kind treatment – to market. Together, these results and the investment from the EIB, position Xeltis to advance confidently toward commercialization, bringing aXess – a revolutionary, first of its kind treatment – to market. Eliane Schutte, Chief Executive Officer, Xeltis, commented: "We are deeply grateful for the...
PR Newswire
02/12/2025
CARBIOS and Wankai New Materials sign the definitive agreement establishing a…
Clermont-Ferrand (France), 2 December 2025 (8:45 AM CET).In line with the commitment signed on November 6, 2025 1, CARBIOS (Euronext Growth Paris: ALCRB) and Wankai New Materials (« Wankai »), a listed subsidiary 2of Zhink Group, the 3 rdlargest PET producer in China and 4 thworldwide, announce the signing of the definitive agreement establishing a strategic partnership for the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia, with the first step being the...
Nasdaq GlobeNewswire
02/12/2025
Proforma reporting of Essity's new business areas
Business areas as of January 1, 2026 Business areas as ofJanuary 1, 2026 Health & Medical Health & Medical encompasses the categories Incontinence Products Health Care and Medical Solutions. The offering includes incontinence products under the globally leading brand TENA and products in wound care, compression therapy and orthopedics under brands such as Leukoplast, Cutimed, JOBST, Actimove and Delta-Cast. Personal Care Personal Care encompasses the categories...
PR Newswire
02/12/2025
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2…
EO2401 in vivoimmune therapy + nivolumab +/- bevacizumab shows survival benefit in first recurrent glioblastomaData presented at 2025 SNO conference by lead investigatorParis, France – 2 DECEMBER 2025 (08:30 CET)Enterome, a clinical-stage company pioneering OncoMimics™ peptides, a new class of off-the-shelf, multi-targetedin vivoimmune therapies that induce a fast and potent expansion of memory T cells to fight cancer,today announces new survival analyses from Cohort 3...
Nasdaq GlobeNewswire
02/12/2025
Lundbeck to present comprehensive new bexicaserin dataset in patients with rare…
"Most DEEs are resistant to conventional anti-seizure medicines, leaving patients with very few options," said Johan Luthman, EVP and Head of Research & Development at Lundbeck. "The data for bexicaserin are compelling—indicating early seizure reductions that are sustained across diverse DEE syndromes. These results underscore its potential as a first-in-class treatment across this devastating range of epilepsies." "Most DEEs are resistant to conventional…
PR Newswire
02/12/2025
Tata Elxsi, University of Illinois Urbana-Champaign, and OSF HealthCare Partner…
Rural areas face steep barriers to healthcare access, including limited technology awareness, long distances to doctors, poor network connectivity, low population density, and inadequate payer coverage. A detailed OSF-based analysis by the Gies College of Business found that extending access to primary and preventive care in remote and rural areas significantly reduces avoidable emergency care visits among these populations. The initiative focuses on chronic and behavioral diseases and addresses…
PR Newswire
02/12/2025
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
COPENHAGEN, Denmark, December 2, 2025– Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months.This decision should be viewed in the context of a current strong cash position, resulting from the recent sale of the Priority Review Voucher and a continued positive cash flow from operations. As of September 30, 2025, securities, cash and cash equivalents were DKK 2,978 million, of...
Nasdaq GlobeNewswire
02/12/2025
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone…
Both medicines were approved by the European Medicines Agency (EMA) in September of this year following trials versus their reference product showing they are highly similar to the Prolia® (Amgen). Both medicines were approved by the European Medicines Agency (EMA) in September of this year following trials versus their reference product showing they are highly similar to the Prolia® (Amgen). Denosumab marks the company's second biosimilar launch within its bone health portfolio, further...
PR Newswire
02/12/2025
Tecan expands robotic workcell offering with acquisition of Wako Automation…
Männedorf, Switzerland, December 2, 2025 –The Tecan Group (SIX Swiss Exchange: TECN) today announced the acquisition of Wako Automation assets, including the flagship Director™ scheduling software and select hardware modules. The transaction was completed on December 1, 2025.It is Tecan’s strategic objective to expand its addressable market beyond liquid-handling-centric offerings and reinforce its leadership in laboratory automation. Advanced scheduling software enables customers to...
Nasdaq GlobeNewswire
02/12/2025
Kuros Biosciences announces enrollment of first patient in ASTRA study – A…
Kuros Biosciences announces enrollment of first patient in ASTRA study –A global, prospective, randomized, multi-center clinical trial in foot and ankle fusionSchlieren (Zürich), Switzerland, December 2, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced that the first patient has been enrolled in its global ASTRA (Ankle Subtalar arThrodesis Randomized Assessment) study. ASTRA is a prospective, randomized,...
Nasdaq GlobeNewswire
02/12/2025
Roche receives FDA clearance with CLIA waiver and CE Mark for its first…
The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and prevent severe complications and onward transmission.Detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity.Early diagnosis can reduce the risk of complications and severe disease in vulnerable groups such as infants and the elderly, by...
Nasdaq GlobeNewswire
02/12/2025
Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034)…
Colorectal Cancer Market Summary Colorectal Cancer Market Summary Discover the colorectal cancer new treatment @New Treatments for Colorectal Cancer Key Factors Driving the Growth of the Colorectal Cancer Market Increasing Colorectal Cancer Incidence The growing global incidence of colorectal cancer is a primary market driver, attributed to aging populations, lifestyle changes, and rising risk factors such as obesity, sedentary habits, diets high in processed meats,...
PR Newswire
01/12/2025
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…
Company AnnouncementCOPENHAGEN, Denmark; December 1, 2025 –Genmab A/S(Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
01/12/2025
/C O R R E C T I O N -- Crisis Prevention Institute/
"Andee's appointment marks the beginning of an exciting new chapter for CPI," said Adam Reinmann and Harper Mates, Managing Directors with Wendel, and members of CPI's Board of Directors. "Her career reflects a dedication to empowering organizations and people, through innovation, digital transformation, and culture building–aligning directly with CPI's mission. We are deeply grateful for Tony Jace's remarkable leadership over the past 16 years. His vision and commitment have…
PR Newswire
01/12/2025
CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit…
CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, bringing together decades of expertise in advanced radiation therapy positioning and immobilization solutions. The CQ Medical portfolio covers a range of clinical applications, including devices for precision stereotactic treatment and proton therapy, implantable fiducial markers for image-guided radiotherapy, customizable thermoplastic patient immobilization, and patient transfer systems for radiotherapy and…
PR Newswire
01/12/2025
EssilorLuxottica creates Scientific Advisory Committee to accelerate the next…
EssilorLuxottica creates Scientific Advisory Committeeto accelerate the next era of innovationParis, France (1 December 2025)– EssilorLuxottica announced the creation of its Scientific Advisory Committee, bringing together some of the world’s most sought-after scientists and thought leaders from the converging fields of science, technology and healthcare. This initiative will reinforce the Group’s enduring scientific foundation and its mission to empower patients and consumers...
Nasdaq GlobeNewswire
01/12/2025
Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars…
Rising healthcare expenditure in key economies, increasing pressure to deliver value-based treatment pathways, and an expanding patient base are all pushing biologics and biosimilars into the mainstream. These therapies are no longer exclusive to advanced hospital systems. Broader regulatory support, strengthened manufacturing capabilities, and strategic investments from major pharmaceutical companies have collectively expanded market accessibility. As chronic diseases become more complex and…
PR Newswire
01/12/2025
Medical Adhesive Tapes Market Surges to USD 5.8 Billion by 2033, Propelled by…
Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=79213&utm_source=PRNewswire&utm_medium=360 Browse in-depth TOC on Medical Adhesive Tapes Market 202 - Pages 126 – Tables 37 – Figures Scope of The Medical Adhesive Tapes Market Report Global Medical Adhesive Tapes Market Overview Medical Adhesive Tapes Market: Trends and Opportunities Executive Market Analysis Market leaders and...
PR Newswire
01/12/2025
Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as…
Cystic fibrosis, a life-long autosomal recessive disorder caused by mutations in the CFTR gene, affects more than 162,000 patients globally, with rising diagnostic rates enabling broader therapeutic adoption. The past five years have shifted the market from symptomatic management to disease-modifying treatments, marking the most significant clinical progress in CF care in decades. Cystic fibrosis, a life-long autosomal recessive disorder caused by mutations in the CFTR gene, affects more than...
PR Newswire
01/12/2025
IVD Labware Market worth $5.04 billion by 2030 with 6.0% CAGR |…
Browse in-depth TOC on "IVD Labware Market" Browse in-depth TOC on "IVD Labware Market" 523 - Tables55 - Figures392 - Pages By application,the IVD labware market is segmented into immunoassays, clinical chemistry, molecular diagnostics, hematology, microbiology, and other applications. In 2024, the clinical chemistry segment accounted for the largest share of the IVD labware market because it supports some of the highest-volume tests performed across diagnostic...
PR Newswire
01/12/2025
OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class…
Preclinical data to be presented by Dr. Gastón Soria, Co-Founder and Chief Scientific Officer, will highlight: Preclinical data to be presented by Dr. Gastón Soria, Co-Founder and Chief Scientific Officer, will highlight: "The selection of ONC001 for an oral presentation at ASH underscores the strength of this fundamentally new therapeutic approach," saidTarek Zaki, Co-Founder & Chief Executive Officer of OncoPrecision. "ONC001 is designed to specifically target resistance…
PR Newswire
01/12/2025
Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market Browse in-depth TOC on "Respiratory Syncytial Virus (RSV) Market" 62 – Tables 57 – Figures 159 – Pages A New Vaccination Era: Why the RSV Market Is Scaling Faster Than Ever Before In the past two years, RSV has shifted from being an overlooked seasonal virus...
PR Newswire
01/12/2025
Dubai Wellness Franchise elegant hoopoe Brings AI-Powered Model to UK as…
The global franchise industry surpassed $890 billion in 2024, yet legacy models struggle to adapt to post-COVID consumer behaviour, rising regulatory complexity and structural inefficiency. Meanwhile, the wellness economy has exceeded $1.5 trillion, with UK consumers increasingly demanding evidence-based, outcomes-driven longevity care. AI-enabled franchises - built on accuracy, adaptability and transparent performance - are rapidly outperforming traditional networks. The global franchise...
PR Newswire
01/12/2025
Altri Comunicati
